{"id":19012,"date":"2022-01-17T08:54:56","date_gmt":"2022-01-17T07:54:56","guid":{"rendered":"https:\/\/www.idisantiago.es\/grupo-de-investigacion\/ac22-trastornos-del-movimiento\/"},"modified":"2026-03-17T12:19:50","modified_gmt":"2026-03-17T11:19:50","slug":"ac22-trastornos-del-movimiento","status":"publish","type":"project","link":"https:\/\/www.idisantiago.es\/en\/grupo-de-investigacion\/ac22-trastornos-del-movimiento\/","title":{"rendered":"E065 \u2013 Translational Research in Neurological Diseases (ITEN)"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||||false|false&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; custom_padding=&#8221;0px||||false|false&#8221; locked=&#8221;on&#8221; collapsed=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>\u00c1REA: <a href=\"https:\/\/www.idisantiago.es\/en\/research-areas-2\/a004-neurociencias\/\">NEUROCIENCIAS<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;2_3,1_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/www.idisantiago.es\/wp-content\/uploads\/2021\/11\/grupo_investigacion.jpg&#8221; title_text=&#8221;Corporate portrait of office workers and employees&#8221; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_toggle title=&#8221;Objectives and lines of research&#8221; admin_label=&#8221;Objetivos y l\u00edneas de investigaci\u00f3n&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>Objectives<\/h3>\n<ul>\n<li>Impulsar una investigaci\u00f3n cl\u00ednica de car\u00e1cter traslacional en enfermedades neurol\u00f3gicas.<\/li>\n<li>Desarrollar biomarcadores en fluidos biol\u00f3gicos para diagn\u00f3stico precoz y seguimiento.<\/li>\n<li>Integrar neuroimagen, t\u00e9cnicas moleculares y an\u00e1lisis bioinform\u00e1ticos en la pr\u00e1ctica cl\u00ednica.<\/li>\n<li>Aplicar inteligencia artificial (IA) y epigen\u00f3mica para avanzar en medicina de precisi\u00f3n.<\/li>\n<li>Trasladar los resultados de laboratorio a la consulta asistencial.<\/li>\n<\/ul>\n<h3>Lines of research<\/h3>\n<ol>\n<li style=\"list-style-type: none;\">\n<ol>\n<li><strong>Biomarcadores y Diagn\u00f3stico Neurol\u00f3gico Avanzado<\/strong>: Desarrollo y aplicaci\u00f3n de biomarcadores en fluidos biol\u00f3gicos (Plataforma de Biomarcadores en Fluidos Biol\u00f3gicos (SIMOA HD-X: <a href=\"https:\/\/www.idisantiago.es\/en\/plataformas-de-apoyo-comun\/plataforma-de-biomarcadores-en-fluidos-biologicos-simoa-hd-x\/\">https:\/\/www.idisantiago.es\/plataformas-de-apoyo-comun\/plataforma-de-biomarcadores-en-fluidos-biologicos-simoa-hd-x\/<\/a>), neuroimagen y t\u00e9cnicas moleculares para el diagn\u00f3stico precoz de enfermedades neurol\u00f3gicas.<\/li>\n<li><strong>Trastornos Cognitivos y Neurodegenerativos<\/strong>: Investigaci\u00f3n en Alzheimer, Esclerosis M\u00faltiple y deterioro cognitivo, integrando epigen\u00e9tica (ej. miARNs), -\u00f3micas, bioinform\u00e1tica (ej. software myBrain-Seq) e inteligencia artificial (IA).<\/li>\n<li><strong>Trastornos del Movimiento<\/strong>: Estudio del Parkinson y otros trastornos motores, con enfoques como ultrasonidos focales (HIFU), estimulaci\u00f3n cerebral profunda y terapias de infusi\u00f3n.<\/li>\n<li><strong>Epilepsia y Enfermedades Asociadas<\/strong>: Diagn\u00f3stico y tratamiento de epilepsia refractaria, gen\u00e9tica de encefalopat\u00edas epil\u00e9pticas, y su relaci\u00f3n con el sue\u00f1o y el espectro autista.<\/li>\n<li><strong>Neuroinmunolog\u00eda, Neuroendocrinolog\u00eda y Rehabilitaci\u00f3n<\/strong>: Estudio de alteraciones inmunometab\u00f3licas en enfermedades neurol\u00f3gicas, barrera hematoencef\u00e1lica, espasticidad, dolor y aplicaci\u00f3n de rob\u00f3tica en neurorehabilitaci\u00f3n.<\/li>\n<\/ol>\n<\/li>\n<\/ol>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Research team&#8221; admin_label=&#8221;Equipo investigador&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<table style=\"width: 100%; border-collapse: collapse; border-style: hidden;\" border=\"0\">\n<tbody>\n<tr>\n<td style=\"width: 50%;\"><strong>Leader<\/strong><br \/>Prieto Gonz\u00e1lez, Jos\u00e9 Mar\u00eda<strong>Coleader<\/strong><br \/>Ag\u00eds Balboa, Roberto Carlos<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Members<\/strong><br \/>Ares Pensado, Bego\u00f1a<br \/>Campos Toimil, Manuel<br \/>Dom\u00ednguez Vivero, Clara<br \/>Fern\u00e1ndez Ceballos, Mar\u00eda de los \u00c1ngeles<br \/>Fern\u00e1ndez Pajar\u00edn, Gustavo<br \/>Figueroa Rodr\u00edguez, Jes\u00fas<br \/>Jim\u00e9nez Mart\u00edn, Isabel<br \/>Ledo Matos, Mar\u00eda Estrella<br \/>L\u00f3pez Gonz\u00e1lez, Francisco Javier<br \/>Piorno Lagos, Vicente<br \/>Prieto Gonz\u00e1lez, \u00c1ngel<br \/>Rodr\u00edguez Osorio, Xiana<br \/>Se\u00f1ar\u00eds Rodr\u00edguez, Mar\u00eda Rosa<br \/>S\u00e9sar Ignacio, \u00c1ngel<br \/>Vidal Nogueira, Lara<br \/>Vi\u00f1a Castelao, Mar\u00eda Dolores<\/p>\n<\/td>\n<td style=\"width: 50%;\">\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Projects&#8221; disabled_on=&#8221;off|off|off&#8221; admin_label=&#8221;Proyectos (cambiar s\u00f3 codigo IDIS)&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; hover_enabled=&#8221;0&#8243; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<strong>Evaluaci\u00f3n de biomarcadores sangu\u00edneos en Suero y Ves\u00edculas Extracelulares de pacientes con Esclerosis M\u00faltiple que reciben tratamientos de alta eficacia<\/strong><br \/>C\u00f3digo del proyecto: PI25\/00435<br \/>Entidad financiadora: Acci\u00f3n Estrat\u00e9gica en Salud (ISCIII)<br \/>Duraci\u00f3n: 2026-2028<br \/>Cuant\u00eda: 148.556,25 \u20ac<br \/>Investigador\/a principal: <a href=\"\"><\/a> <br \/><\/p>\n<p><strong>Ayudas a grupos de referencia competitiva (GRC)<\/strong><br \/>C\u00f3digo del proyecto: ED431C 2023\/22<br \/>Entidad financiadora: Xunta de Galicia<br \/>Duraci\u00f3n: 2023-2026<br \/>Cuant\u00eda: 280.000 \u20ac<br \/>Investigador\/a principal: <a href=\"\"><\/a> Rosa Mar\u00eda Se\u00f1ar\u00eds Rodr\u00edguez<br \/><\/p>\n<p><strong>\u200bEvaluaci\u00f3n del deterioro cognitivo (screening y progresi\u00f3n) usando inteligencia artificial y biomarcadores epigen\u00f3micos en poblaci\u00f3n de ancianos (COGNISANCE)<\/strong><br \/>C\u00f3digo del proyecto: PID2022-138936OB-C31<br \/>Entidad financiadora: Ministerio de Ciencia e Innovaci\u00f3n<br \/>Duraci\u00f3n: 2023-2026<br \/>Cuant\u00eda: 237.500 \u20ac<br \/>Investigador\/a principal: <a href=\"\"><\/a> <br \/><\/p>\n<p><strong>Efecto del sensor de frio TRPM8 en la regulaci\u00f3n epigen\u00f3mica, transcripcional y circadiana de la homeostasis energ\u00e9tica: Nuevas oportunidades terap\u00e9uticas en la obesidad<\/strong><br \/>C\u00f3digo del proyecto: PID2021- 124785OB-I00<br \/>Entidad financiadora: Agencia Estatal de Investigaci\u00f3n<br \/>Duraci\u00f3n: 2022-2025<br \/>Cuant\u00eda: 181.500 \u20ac<br \/>Investigador\/a principal: <a href=\"\"><\/a> Rosa Mar\u00eda Se\u00f1ar\u00eds Rodr\u00edguez<br \/><\/p>\n<p><strong>Estimulaci\u00f3n de las rutas de NO\/GMPc y AMPc en la barrera hematoencef\u00e1lica: una nueva estrategia terape\u00fatica frente a la enfermedad de Alzheimer<\/strong><br \/>C\u00f3digo del proyecto: PID2020-119178GB-I00<br \/>Entidad financiadora: Ministerio de Ciencia, Innovaci\u00f3n y Universidades<br \/>Duraci\u00f3n: 2021-2023<br \/>Cuant\u00eda: 84.700 \u20ac<br \/>Investigador\/a principal: <a href=\"\"><\/a> Manuel Campos Toimil<br \/><\/p>\n<p><strong>B\u00fasqueda de biomarcadores y estudio del microARNoma del deterioro cognitivo asociado a la depresi\u00f3n<\/strong><br \/>C\u00f3digo del proyecto: PI18\/01311<br \/>Entidad financiadora: Acci\u00f3n Estrat\u00e9gica en Salud (ISCIII)<br \/>Duraci\u00f3n: 2019-2023<br \/>Cuant\u00eda: 113.320 \u20ac<br \/>Investigador\/a principal: <a href=\"\"><\/a> <br \/><\/p>\n<p>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Publications&#8221; disabled_on=&#8221;off|off|off&#8221; admin_label=&#8221;Publicaciones&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<ul>\n<li>Campanioni S, Veiga C, Prieto-Gonz\u00e1lez JM, Gonz\u00e1lez-N\u00f3voa JA, Busto L, Martinez C, Alberte-Woodward M, Garc\u00eda de Soto J, Pouso-Diz J, Fern\u00e1ndez Ceballos ML\u00c1, Agis-Balboa RC. <strong>Explainable machine learning on baseline MRI predicts multiple sclerosis trajectory descriptors.<\/strong> <em>PLoS One<\/em>. 2024 <a href=\"https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0306999\"><span style=\"color: #808000;\"><strong>DOI: 10.1371\/journal.pone.0306999<\/strong><\/span><\/a><\/li>\n<li>G. Fern\u00e1ndez-Pajar\u00edn, M. Blanco-Ulla, E. Ar\u00e1n, B. Ares, P. Rom\u00e1n-Pena, A. Jes\u00fas Mosqueira, I. Jim\u00e9nez-Mart\u00edn, M. Gelabert-Gonz\u00e1lez, J.M. Prieto-Gonz\u00e1lez &amp; \u00c1. Sesar. <strong>Unilateral Thalamotomy with High-Intensity Focused Ultrasound in Refractory Tremor. First Results of a Public Hospital in Spain. <\/strong><em>Neurolog\u00eda. <\/em>2024. <span style=\"color: #808000;\"><strong><a style=\"color: #808000;\" href=\"https:\/\/www.clinicalkey.es\/#!\/content\/playContent\/1-s2.0-S0213485324001452?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0213485324001452%3Fshowall%3Dtrue&amp;referrer=\">DOI: 10.1016\/j.nrl.2023.02.012<\/a><\/strong><\/span>.<\/li>\n<li>Oreja-Guevara C, Mart\u00ednez-Y\u00e9lamos S, Eichau S, et al.<strong> Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management<\/strong>. <em>Ther Adv Neurol Disord<\/em>.\u00a02024 Oct 16;17. <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11526321\/\"><span style=\"color: #808000;\"><strong><span class=\"identifier doi\"><span class=\"id-label\">DOI: 10.1177\/17562864241284372<\/span><\/span><\/strong><\/span><\/a><\/li>\n<li>Fern\u00e1ndez-Pereira C, Fern\u00e1ndez-Ceballos MA, Olivares JM, Prieto-Gonz\u00e1lez JM, Ag\u00eds-Balboa RC<strong>. Neurofilament light chain (NfL) plasma levels in Major Depressive Disorder: a brief research report<\/strong>. <em>Front Psychiatry<\/em>. 2024 Nov 14;15:1476248. <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11602450\/\"><span style=\"color: #808000;\"><strong><span class=\"identifier doi\"><span class=\"id-label\">DOI: 10.3389\/fpsyt.2024.1476248<\/span><\/span><\/strong><\/span><\/a><\/li>\n<li>Oreja-Guevara C, Meca-Lallana JE, D\u00edaz-D\u00edaz J, et al. <strong>Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study<\/strong>. <em>Mult Scler Relat Disord<\/em>. 2024 90:105787. <a href=\"https:\/\/www.clinicalkey.es\/#!\/content\/playContent\/1-s2.0-S221103482400364X?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS221103482400364X%3Fshowall%3Dtrue&amp;referrer=https:%2F%2Fpubmed.ncbi.nlm.nih.gov%2F\"><span style=\"color: #808000;\"><strong><span class=\"identifier doi\"><span class=\"id-label\">DOI: 10.1016\/j.msard.2024.105787<\/span><\/span><\/strong><\/span><\/a><\/li>\n<li>P\u00e9rez-Rodr\u00edguez D, Ar\u00e1nzazu Penedo M, Rivera-Baltan\u00e1s T, Pe\u00f1a-Centeno T, Burkhardt S, Fischer A, Prieto-Gonzalez JM, Olivares JM, L\u00f3pez-Fern\u00e1ndez H &amp; Ag\u00eds-Balboa RC. <strong>MiRNA Differences Related to Treatment-Resistant Schizophrenia.<\/strong> Int J Mol Sci. 2023, 24(3):1891. <a href=\"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/1891\"><span style=\"color: #808000;\"><strong><span class=\"identifier doi\"><span class=\"id-label\">DOI: doi.org\/10.3390\/ijms24031891<\/span><\/span><\/strong><\/span><\/a><\/li>\n<li>P\u00e9rez-Rodr\u00edguez D, Ag\u00eds-Balboa RC, L\u00f3pez-Fern\u00e1ndez H.<strong> myBrain-Seq: a pipeline for miRNA-seq data analysis in neuropsychiatric disorders<\/strong>. <em>Biomedicines<\/em>. 2023 11(4):1230. <a href=\"https:\/\/www.mdpi.com\/2227-9059\/11\/4\/1230\"><span style=\"color: #808000;\"><strong><span class=\"identifier doi\"><span class=\"id-label\">DOI: doi.org\/10.3390\/biomedicines11041230<\/span><\/span><\/strong><\/span><\/a><\/li>\n<li>Reim\u00fandez A, Fern\u00e1ndez-Pe\u00f1a C, Ord\u00e1s P, Hern\u00e1ndez-Ortego P, Gallego R, Morenilla-Palao C, Navarro J, Mart\u00edn-Cora F, Pardo-V\u00e1zquez JL, Schwarz LA, Arce V, Viana F, Se\u00f1ar\u00eds R.<strong> The cold-sensing ion channel TRPM8 regulates central and peripheral clockwork and the circadian oscillations of body temperature<\/strong>. <em>Acta Physiol (Oxf)<\/em>. 2023, 237(3):e13896. <a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apha.13896\"><span style=\"color: #808000;\"><strong><span class=\"identifier doi\"><span class=\"id-label\">DOI: 10.1111\/apha.13896<\/span><\/span><\/strong><\/span><\/a><\/li>\n<\/ul>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Web del grupo&#8221; disabled_on=&#8221;on|on|on&#8221; admin_label=&#8221;Web del grupo&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; disabled=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>https:\/\/<\/p>\n<p>[\/et_pb_toggle][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text admin_label=&#8221;Investigador\/a l\u00edder&#8221; _builder_version=&#8221;4.19.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; header_text_color=&#8221;#FFFFFF&#8221; header_2_text_align=&#8221;left&#8221; header_2_text_color=&#8221;#FFFFFF&#8221; background_color=&#8221;#10294c&#8221; custom_margin=&#8221;0px||||false|false&#8221; custom_padding=&#8221;6px||0px|6px|false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Lead researcher<\/h2>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;WP Team (cambiar s\u00f3 a ID pola do l\u00edder de equipo)&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div class=\"sp-wp-team-pro-wrapper wp-team-pro-preloader\" >\n\n<div id=\"sptp-10741\" class=\"sp-team-pro sptp-section sptp-new_page pagination_normal sptp-even\" >\n\n\t<div class=\"sp-team-pro-page-loading-image\"><\/div>\n\t<div class=\"sptp-grid\">\n\t\t<div class=\"sptp-row  \">\n\t\t\t\t\t<div class=\"sp-team-pro-item sptp-col-lg-1 sptp-col-md-1 sptp-col-sm-1 sptp-col-xs-1\"\n\t\t\t data-member=\"18833\">\n\t\t\t\t<div class=\"sptp-member  border-bg-around-member sptp-square\">\n\t<a class=\"sptp-member-avatar \"  href=https:\/\/www.idisantiago.es\/en\/team\/jose-maria-prieto-gonzalez\/ target=_blank >\n\t<div class=\"sptp-member-avatar-img-area\" data-id=\"18833\">\n\t\t<div class=\"sptp-member-avatar-img sptp-square sptp-icon-on-image none \">\n\t\t\t<div class=\"sptp-overflow-h\">\n\t\t\t\t\t\t\t\t\t<div class=\"sptp-icon text-center\">\n\t\t\t\t\t<i class=\"fa fa-plus\"><\/i>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"sptp_default_img\" srcset=\"https:\/\/www.idisantiago.es\/wp-content\/uploads\/2022\/02\/PRIETO_AC22-2-320x320.jpg\" src=\"https:\/\/www.idisantiago.es\/wp-content\/uploads\/2022\/02\/PRIETO_AC22-2-320x320.jpg\" alt=\"Jos\u00e9 Mar\u00eda Prieto Gonz\u00e1lez\" width=\"320\" height=\"320\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/a>\n\t<div class=\"sptp-member-name \">\n\t\t<h2>\n\t\t\t\t\tJos\u00e9 Mar\u00eda Prieto Gonz\u00e1lez\t\t\t\t<\/h2>\n\t<\/div>\n<div class=\"sptp-member-email\">\n\n<i class=\"fa fa-envelope\"><\/i>\t<a href=\"#0\"  class=\"\">\n\t\t<span>josemaoscar.prieto@usc.es<\/span>\n\t<\/a>\n\t<\/div>\n<div class=\"sptp-member-phone\">\n<i class=\"fa fa-phone\"><\/i>\t<a href=\"#0\"  class=\"\" >\n\t\t<span>(+34) 981 951 344<\/span>\n\t<\/a>\n\t<\/div>\n<div class=\"sptp-read-more-button\">\n\t<a class=\"sptp-member-read-more-button\" href=\"https:\/\/www.idisantiago.es\/en\/team\/jose-maria-prieto-gonzalez\/\"> + INFO <\/a>\n<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div> <!-- end row -->\n\t<\/div> <!-- end grid -->\n\t\t\t<\/div>\n<\/div>\n\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;Investigador\/a l\u00edder&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; header_text_color=&#8221;#FFFFFF&#8221; header_2_text_align=&#8221;left&#8221; header_2_text_color=&#8221;#FFFFFF&#8221; background_color=&#8221;#10294c&#8221; custom_margin=&#8221;0px||||false|false&#8221; custom_padding=&#8221;6px||0px|6px|false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Colead researcher<\/h2>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;WP Team (cambiar s\u00f3 a ID pola do l\u00edder de equipo)&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div class=\"sp-wp-team-pro-wrapper wp-team-pro-preloader\" >\n\n<div id=\"sptp-44046\" class=\"sp-team-pro sptp-section sptp-new_page pagination_normal sptp-even\" >\n\n\t<div class=\"sp-team-pro-page-loading-image\"><\/div>\n\t<div class=\"sptp-grid\">\n\t\t<div class=\"sptp-row  \">\n\t\t\t\t\t<div class=\"sp-team-pro-item sptp-col-lg-1 sptp-col-md-1 sptp-col-sm-1 sptp-col-xs-1\"\n\t\t\t data-member=\"44039\">\n\t\t\t\t<div class=\"sptp-member  border-bg-around-member sptp-square\">\n\t<a class=\"sptp-member-avatar \"  href=https:\/\/www.idisantiago.es\/team\/roberto-carlos-agis-balboa\/ target=_blank >\n\t<div class=\"sptp-member-avatar-img-area\" data-id=\"44039\">\n\t\t<div class=\"sptp-member-avatar-img sptp-square sptp-icon-on-image none \">\n\t\t\t<div class=\"sptp-overflow-h\">\n\t\t\t\t\t\t\t\t\t<div class=\"sptp-icon text-center\">\n\t\t\t\t\t<i class=\"fa fa-plus\"><\/i>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"sptp_default_img\" srcset=\"https:\/\/www.idisantiago.es\/wp-content\/uploads\/2026\/01\/WhatsApp-Image-2026-01-15-at-09.29.39-e1768546417105-320x320.jpeg\" src=\"https:\/\/www.idisantiago.es\/wp-content\/uploads\/2026\/01\/WhatsApp-Image-2026-01-15-at-09.29.39-e1768546417105-320x320.jpeg\" alt=\"Roberto Carlos Ag\u00eds Balboa\" width=\"320\" height=\"320\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/a>\n\t<div class=\"sptp-member-name \">\n\t\t<h2>\n\t\t\t\t\tRoberto Carlos Ag\u00eds Balboa\t\t\t\t<\/h2>\n\t<\/div>\n<div class=\"sptp-member-email\">\n\n<i class=\"fa fa-envelope\"><\/i>\t<a href=\"#0\"  class=\"\">\n\t\t<span>Roberto.Carlos.Agis.Balboa@sergas.es<\/span>\n\t<\/a>\n\t<\/div>\n<div class=\"sptp-read-more-button\">\n\t<a class=\"sptp-member-read-more-button\" href=\"https:\/\/www.idisantiago.es\/team\/roberto-carlos-agis-balboa\/\"> + INFO <\/a>\n<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div> <!-- end row -->\n\t<\/div> <!-- end grid -->\n\t\t\t<\/div>\n<\/div>\n\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00c1REA: NEUROCIENCIASObjectives Impulsar una investigaci\u00f3n cl\u00ednica de car\u00e1cter traslacional en enfermedades neurol\u00f3gicas. Desarrollar biomarcadores en fluidos biol\u00f3gicos para diagn\u00f3stico precoz y seguimiento. Integrar neuroimagen, t\u00e9cnicas moleculares y an\u00e1lisis bioinform\u00e1ticos en [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":13787,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"project_category":[510],"project_tag":[],"class_list":["post-19012","project","type-project","status-publish","has-post-thumbnail","hentry","project_category-neurociencias-en"],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/project\/19012","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/comments?post=19012"}],"version-history":[{"count":33,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/project\/19012\/revisions"}],"predecessor-version":[{"id":45694,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/project\/19012\/revisions\/45694"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/media\/13787"}],"wp:attachment":[{"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/media?parent=19012"}],"wp:term":[{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/project_category?post=19012"},{"taxonomy":"project_tag","embeddable":true,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/project_tag?post=19012"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}